Is the shorter (hypofractionated) course as effective as the longer one?

Breast Cancer Radiotherapy in Istanbul

In short

Whole-breast radiotherapy at Istanbul hospitals runs $6,500–9,500 (illustrative placeholder) — about 71% less than Germany. Most courses today are hypofractionated (~3 weeks). A free 72h second opinion reviews your case.

Whole-breast radiotherapy after breast-conserving surgery at Istanbul hospitals runs $6,500–9,500 as an illustrative placeholder range pending Q3 2026 verified quotes — about 71% less than typical German prices for the same protocol. Most courses today use a shorter, hypofractionated schedule (about 3 weeks) rather than the older 5-6 week course. A free 72-hour tumor-board second opinion reviews whether radiotherapy is indicated in your case and which schedule fits.

What it costs

UPDATED Q3 2026PLACEHOLDER — PENDING Q3 2026 QUOTES

Radiotherapy course, IMRT/VMAT

$6,500–9,500

Germany typical $28,000 · −71%

Includes CT simulation, physics planning + QA, all fractions, weekly physician review, final report. Ranges come from partner-hospital quotes, updated quarterly.

Get an exact quote for your case

What it costs

Q3 2026

IMRT/VMAT course

$6,500–9,500

Germany: $28,000 · placeholder

Get an exact quote for your case

When radiotherapy is indicated

Standard after breast-conserving surgery for early-stage disease and DCIS; also used after mastectomy for higher-risk features. Most courses today are hypofractionated (~3 weeks) rather than the older 5-6 week schedule.

Radiotherapy after breast-conserving surgery (lumpectomy) is standard for early-stage invasive breast cancer and for DCIS, aimed at destroying any remaining cancer cells in the breast tissue. It is also used after mastectomy for higher-risk features, such as a larger tumor or several involved lymph nodes. Most courses today use hypofractionation — larger daily doses over about 3 weeks — shown to be as safe and effective as the older 5-6 week conventional schedule for most patients.

Radiotherapy is typically appropriate when

Breast-conserving surgery already performed · early-stage invasive cancer or DCIS · higher-risk features after mastectomy (large tumor, multiple positive nodes)

The board may advise a different approach when

Very small, node-negative tumors in select older patients where omission is sometimes reasonable · prior radiotherapy to the same area · certain connective-tissue conditions raising toxicity risk

Not sure radiotherapy applies to you?

Send your reports — the tumor board answers in 72 hours. Free, no travel.

Upload reports

The course

Whole-breast (hypofractionated)Whole-breast irradiation (hypofractionated)

outpatient · ~15 fractions · 3 weeks

Daily external-beam radiation to the whole breast, about 3 weeks (~15 fractions). A boost to the tumor site is sometimes added for higher-risk cases.External-beam radiation is delivered to the whole breast once daily, typically over about 3 weeks (roughly 15 fractions) at a slightly higher dose per session than the older schedule — shown in large trials to be equally effective and safe for most early-stage cases. A boost to the original tumor bed is sometimes added for higher-risk cases.

Typical timeline

Planning → start

Course length

Follow-up

Whole-breast irradiation

1–2 weeks (CT simulation)

~3 weeks, outpatient

within days of completion

Not sure radiotherapy applies to you?

Free 72h answer — upload reports

Who delivers radiotherapy

Verified, consented surgeon profiles are being onboarded — illustrative example profiles are shown elsewhere on the site while we complete verification.

Hospital options

Two states of the same component — before and after your personal quote.

state 1 · pre-quote (anonymized)

Hospital AJCI

$9,200–11,800

Hospital BJCI

$8,500–10,400

Hospital C

$10,900–12,600

Names revealed with your personal quote

state 2 · post-quote (named)

Pera Oncology Center

Named in your quote[placeholder name]

Your itemized quote$8,200

Ask about this quote

Fair questionsFair questions about breast radiotherapy

For most early-stage cases, yes — trials found it equally effective and safe. It's now the standard recommendation, not an alternative.

For most early-stage cases, yes — large trials found hypofractionated whole-breast radiotherapy equally effective and safe compared with the older, longer schedule, which is why it's now the standard recommendation for most patients rather than an alternative.

Every cancer case is individual. Assessments are based on the reports you provide and do not replace in-person examination. Survival statistics are population-level data, not personal predictions.

Standard radiotherapy (IMRT/VMAT) explained →Breast cancer treatment hub →IMRT/VMAT course prices →

Verify at

Radiation Therapy | Breast Cancer Treatment — National Cancer Institute (NCI)

Treatment of Breast Cancer by Stage — National Cancer Institute (NCI)